Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis

BACKGROUND: World Health Organization step III opioids are required to relieve moderate-to-severe cancer pain; constipation is one of the most frequent opioid-induced side effects. A fixed combination, prolonged-release oxycodone/naloxone (OXN), was developed with the aim of reducing opioid-related...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Drug Des Devel Ther
Auteurs principaux: Lazzari, Marzia, Greco, Maria Teresa, Marcassa, Claudio, Finocchi, Simona, Caldarulo, Clarissa, Corli, Oscar
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2015
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636087/
https://ncbi.nlm.nih.gov/pubmed/26586937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S92998
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires